A carregar...

Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?

Controversy exists regarding the optimal use of the 23-valent pneumococcal conjugate vaccine for the protection of high-risk individuals, such as children and adults with immunocompromising conditions and the elderly. The effectiveness and immunogenicity of 23-valent pneumococcal polysaccharide vacc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Vaccine Immunol
Main Authors: Papadatou, Ioanna, Spoulou, Vana
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860474/
https://ncbi.nlm.nih.gov/pubmed/27009210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00721-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!